Literature DB >> 10894363

The expression and activation of matrix metalloproteinase-2 in rat brain after implantation of C6 rat glioma cells.

T Kodera1, T Nakagawa, T Kubota, M Kabuto, K Sato, H Kobayashi.   

Abstract

It has been reported that matrix metalloproteinases (MMPs) are highly expressed in malignant glioma cells and that this increased expression may facilitate the invasiveness of tumor cells. The authors investigated the expression and enzymatic activity of MMPs in rat brain during the growth of malignant gliomas at different time intervals. C6 rat glioma cells were unilaterally implanted into rat cerebral hemispheres. After 7 or 14 days, these brain tissues were prepared for SDS-PAGE zymography, Western blotting, immunohistochemistry, and in situ zymography. SDS-PAGE zymography and Western blotting revealed that the expression of proMMP-2 in rat brains with C6 glioma cells was significantly higher than that in normal or the sham-operated rat brains, and that the activated form of MMP-2 was detected only in the former but not in the latter. On immunohistochemistry, C6 glioma cells presenting invasive growth into the rat brain parenchyma and vessels demonstrated MMP-2 immunoreactivity. On in situ zymography, foci of invasive C6 glioma cells in rat brain tissue showed gelatinolytic activity. These results suggest that expression and activation of MMP-2 may be one of the crucial steps for glioma cell invasion into the brain parenchyma in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894363     DOI: 10.1023/a:1006387600909

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  42 in total

1.  Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells.

Authors:  N Nagano; H Sasaki; M Aoyagi; K Hirakawa
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

2.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

Authors:  M S Hibbs; K A Hasty; J M Seyer; A H Kang; C L Mainardi
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

3.  Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.

Authors:  E I Deryugina; G X Luo; R A Reisfeld; M A Bourdon; A Strongin
Journal:  Anticancer Res       Date:  1997 Sep-Oct       Impact factor: 2.480

4.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.

Authors:  A Nakano; E Tani; K Miyazaki; Y Yamamoto; J Furuyama
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

5.  Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo.

Authors:  R Sawaya; Y Go; A P Kyritisis; J Uhm; B Venkaiah; S Mohanam; Z L Gokaslan; J S Rao
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

6.  Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.

Authors:  T Nakagawa; T Kubota; M Kabuto; K Sato; H Kawano; T Hayakawa; Y Okada
Journal:  J Neurosurg       Date:  1994-07       Impact factor: 5.115

7.  Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.

Authors:  R E Sawaya; M Yamamoto; Z L Gokaslan; S W Wang; S Mohanam; G N Fuller; I E McCutcheon; W G Stetler-Stevenson; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

8.  Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan.

Authors:  J Zuo; T A Ferguson; Y J Hernandez; W G Stetler-Stevenson; D Muir
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

9.  Matrix metalloproteinase-2 activation modulates glioma cell migration.

Authors:  E I Deryugina; M A Bourdon; G X Luo; R A Reisfeld; A Strongin
Journal:  J Cell Sci       Date:  1997-10       Impact factor: 5.285

10.  Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease.

Authors:  P A Paganetti; P Caroni; M E Schwab
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  5 in total

Review 1.  C6 cell line: the gold standard in glioma research.

Authors:  D Giakoumettis; A Kritis; N Foroglou
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

2.  Studies on the neuroprotective role of Piper longum in C6 glioma induced rats.

Authors:  Umadevi Subramanian; Sharmila Poongavanam; A J Vanisree
Journal:  Invest New Drugs       Date:  2010-10       Impact factor: 3.850

3.  Micropatterned surfaces functionalized with electroactive peptides for detecting protease release from cells.

Authors:  Dong-Sik Shin; Ying Liu; Yandong Gao; Timothy Kwa; Zimple Matharu; Alexander Revzin
Journal:  Anal Chem       Date:  2012-12-14       Impact factor: 6.986

4.  Activating transcription factor 3 is overexpressed in human glioma and its knockdown in glioblastoma cells causes growth inhibition both in vitro and in vivo.

Authors:  Siqi Ma; Changhe Pang; Laijun Song; Fuyou Guo; Hongwei Sun
Journal:  Int J Mol Med       Date:  2015-04-07       Impact factor: 4.101

5.  Quantifying the A1AR distribution in peritumoural zones around experimental F98 and C6 rat brain tumours.

Authors:  Markus Dehnhardt; Christoph Palm; Andrea Vieten; Andreas Bauer; Uwe Pietrzyk
Journal:  J Neurooncol       Date:  2007-05-12       Impact factor: 4.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.